Literature DB >> 19272392

Models for Trypanosoma evansi (surra), its control and economic impact on small-hold livestock owners in the Philippines.

R J Dobson1, A P Dargantes, R T Mercado, S A Reid.   

Abstract

Simple demographic and infectious disease models of buffaloes and other domestic hosts for animal trypanosomosis (surra) caused by Trypanosoma evansi were developed. The animal models contained deterministic and stochastic elements and were linked to simulate the benefit of control regimes for surra in village domestic animal populations in Mindanao, Philippines. The impact of the disease on host fertility and mortality were key factors in determining the economic losses and net-benefit from the control regimes. If using a high (99%) efficacy drug in surra-moderate to high risk areas, then treating all animals twice each year yielded low prevalence in 2 years; targeted treatment of clinically sick animals, constantly monitored (monthly), required 75% fewer treatments but took longer to reach a low prevalence than treating all animals twice each year. At high drug efficacy both of these treatment strategies increased the benefit over untreated animals by 81%. If drug efficacy declined then the benefit obtained from twice yearly treatment of all animals declined rapidly compared with regular monitoring and targeting treatment to clinically sick animals. The current control regimen applied in the Philippines of annual sero-testing for surra and only treating sero-positive animals provided the lowest net-benefit of all the control options simulated and would not be regarded as effective control. The total net-benefit from effective surra control for a typical village in a moderate/high risk area was 7.9 million pesos per annum (US $158,000). The value added to buffaloes, cattle, horses, goats/sheep and pigs as a result of this control was US $88, $84, $151, $7, $114 per animal/year, respectively.

Entities:  

Mesh:

Year:  2009        PMID: 19272392     DOI: 10.1016/j.ijpara.2009.02.013

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  11 in total

1.  Estimating the economic impact of Trypanosoma evansi infection on production of camel herds in Somaliland.

Authors:  Abdirahman Abdikadir Salah; Ian Robertson; Abdullahi Mohamed
Journal:  Trop Anim Health Prod       Date:  2015-02-28       Impact factor: 1.559

2.  Classico-molecular targeting of oligopeptidase B, cysteine protease and variable surface glycoprotein (VSG) genes of Trypanosoma evansi.

Authors:  Ruchi Singh Gaur; Vikrant Sudan; Amit Kumar Jaiswal; Amit Singh; Daya Shanker
Journal:  J Parasit Dis       Date:  2016-03-16

3.  Modelling the potential benefits of different strategies to control infection with Trypanosoma evansi in camels in Somaliland.

Authors:  Abdirahman Salah; Ian Robertson; Abdullahi Sheikh Mohamed
Journal:  Trop Anim Health Prod       Date:  2015-10-30       Impact factor: 1.559

4.  Seroprevalence of Trypanosoma evansi in cattle and analysis of associated climatic risk factors in Mizoram, India.

Authors:  A G S Chandu; P P Sengupta; S S Jacob; K P Suresh; S K Borthakur; G Patra; P Roy
Journal:  J Parasit Dis       Date:  2020-11-03

Review 5.  Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects.

Authors:  Marc Desquesnes; Alan Dargantes; De-Hua Lai; Zhao-Rong Lun; Philippe Holzmuller; Sathaporn Jittapalapong
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

Review 6.  The animal trypanosomiases and their chemotherapy: a review.

Authors:  Federica Giordani; Liam J Morrison; Tim G Rowan; Harry P DE Koning; Michael P Barrett
Journal:  Parasitology       Date:  2016-10-10       Impact factor: 3.234

7.  Expression of the RNA-binding protein RBP10 promotes the bloodstream-form differentiation state in Trypanosoma brucei.

Authors:  Elisha Mugo; Christine Clayton
Journal:  PLoS Pathog       Date:  2017-08-11       Impact factor: 6.823

8.  New Trypanosoma evansi Type B Isolates from Ethiopian Dromedary Camels.

Authors:  Hadush Birhanu; Tadesse Gebrehiwot; Bruno Maria Goddeeris; Philippe Büscher; Nick Van Reet
Journal:  PLoS Negl Trop Dis       Date:  2016-04-01

9.  Transcriptomes of Trypanosoma brucei rhodesiense from sleeping sickness patients, rodents and culture: Effects of strain, growth conditions and RNA preparation methods.

Authors:  Julius Mulindwa; Kevin Leiss; David Ibberson; Kevin Kamanyi Marucha; Claudia Helbig; Larissa Melo do Nascimento; Eleanor Silvester; Keith Matthews; Enock Matovu; John Enyaru; Christine Clayton
Journal:  PLoS Negl Trop Dis       Date:  2018-02-23

10.  The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.

Authors:  Daniela Begolo; Isabel M Vincent; Federica Giordani; Ina Pöhner; Michael J Witty; Timothy G Rowan; Zakaria Bengaly; Kirsten Gillingwater; Yvonne Freund; Rebecca C Wade; Michael P Barrett; Christine Clayton
Journal:  PLoS Pathog       Date:  2018-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.